Highlights PTC Therapeutics, Inc.

Equities

PTCT

US69366J2006

Real-time Estimate Cboe BZX Other stock markets 10:05:58 2024-06-10 am EDT			5-day change	1st Jan Change
36.46 ^USD	-0.18%		-2.48%	+32.44%

May. 24	Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing	MT
May. 21	Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Mixed Pre-Bell Monday	May. 20	MT
Sector Update: Health Care	May. 20	MT
PTC Therapeutics Says European Commission Seeking Review of Negative Opinion on Translarna	May. 20	MT
Sector Update: Health Care Stocks Steady Premarket Tuesday	May. 14	MT
Sector Update: Health Care	May. 14	MT
PTC Therapeutics Gets FDA Priority Review for Upstaza Biologics License Application	May. 14	MT
PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza	May. 14	CI
North American Morning Briefing : More Earnings -2-	Apr. 30	DJ
Sector Update: Health Care Stocks Edge Higher Late Afternoon	Apr. 26	MT
Sector Update: Health Care	Apr. 26	MT
PTC Therapeutics Shares Rise After Better-Than-Expected Q1 Results	Apr. 26	MT
Earnings Flash (PTCT) PTC THERAPEUTICS Posts Q1 Revenue $210.1M, vs. Street Est of $163.8M	Apr. 25	MT
PTC Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
PTC Therapeutics, Inc. Reaffirms Earnings Guidance for the Year 2024	Apr. 25	CI
PTC Therapeutics, Inc. Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA	Mar. 28	CI
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza? as a Treatment for AADC Deficiency	Mar. 19	CI
PTC Therapeutics Shares Jump Following Q4 Results	Mar. 01	MT
PTC Therapeutics Q4 Loss Narrows, Sales Up; Sets Guidance; Shares Slump After-Hours	Feb. 29	MT
PTC Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
PTC Therapeutics, Inc. Provides Earnings Guidance for the Year 2024	Feb. 29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights PTC Therapeutics, Inc.

Equities

PTCT

US69366J2006

Highlights

Filters